Status:
RECRUITING
Global collaboRAtion on CIC-DUX4, BCOR-CCN3, High-grade Undifferentiated Round Cell Sarcoma (URCS) Project
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Undifferentiated Round Cell Sarcoma
Eligibility:
All Genders
Brief Summary
Experimental study with biological material : case series review of clinical and histological data
Detailed Description
This is a multicenter retrospective and prospective study that will analyze all cases with a diagnosis of Undifferentiated round cell sarcomas from 01 January 1983 and all new cases referring to each ...
Eligibility Criteria
Inclusion
- Patients with undifferentiated round cell sarcomas treated from 01 January 1983 and all new patients will be included.
- Clinical and outcome information available.
- Histological slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to perform the histology analysis/frozen tissue representative of the tumor available.
Exclusion
- Diagnosis different from undifferentiated round cell sarcomas
- Patient with no clinical or outcome information available
Key Trial Info
Start Date :
June 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT05357768
Start Date
June 11 2019
End Date
December 31 2028
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCs Istituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136